Evidence map›Paper›PMID 42769458›Full record

ArticleOncology research2026

Autophagy Inhibition Enhances the Antitumor Efficacy of MET Targeting in MET-High Pancreatic Cancer.

Zhiyi Min, Chunbin Wang, Tongjin Yin, Wanyan Jiao, Dandan Zhou, Xuyao Zhang, Junli Cui, Zhe Ding

Abstract read
In one paragraph

Article in Oncology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhiyi MinDepartment of Pharmacy, Yancheng Third People's Hospital (The Affiliated Hospital of Jiangsu Medical College and the Affiliated Hospital 6 of Nantong University), Yancheng, China.ORCID https://orcid.org/0000-0003-0469-2326
Chunbin WangDepartment of Oncology, Yancheng Third People's Hospital (The Affiliated Hospital of Jiangsu Medical College and the Affiliated Hospital 6 of Nantong University), Yancheng, China.
Tongjin YinDepartment of Pediatrics, Yancheng Third People's Hospital (The Affiliated Hospital of Jiangsu Medical College and the Affiliated Hospital 6 of Nantong University), Yancheng, China.
Wanyan JiaoDepartment of Pediatrics, Yancheng Third People's Hospital (The Affiliated Hospital of Jiangsu Medical College and the Affiliated Hospital 6 of Nantong University), Yancheng, China.
Dandan ZhouDepartment of Oncology, Yancheng Third People's Hospital (The Affiliated Hospital of Jiangsu Medical College and the Affiliated Hospital 6 of Nantong University), Yancheng, China.
Xuyao ZhangDepartment of Biological Medicines and Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai, China.
Junli CuiDepartment of Pharmacy, The Affiliated Dongtai Hospital of Nantong University, Yancheng, China.
Zhe DingDepartment of Pharmacy, Yancheng Third People's Hospital (The Affiliated Hospital of Jiangsu Medical College and the Affiliated Hospital 6 of Nantong University), Yancheng, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AutophagyPancreatic NeoplasmsProtein Kinase InhibitorsProto-Oncogene Proteins c-metAnimalsApoptosisCell Line, TumorCell ProliferationCell SurvivalChloroquineHumansMiceSignal TransductionXenograft Model Antitumor AssaysChloroquineMET protein, humanProtein Kinase InhibitorsProto-Oncogene Proteins c-metautophagycombination therapyMETpancreatic cancerSavolitinib

Identifiers

PMID42769458
PMCPMC13591368

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.